Stock market analyst Anil Singhvi is of the view that investors can buy Dabur India Limited stock to achieve an intraday target of Rs 205.

According to analyst, the investors can buy the stock with stop loss of Rs 194.

The shares of the company, on June 08, closed at Rs 196.05 the Bombay Stock Exchange (BSE). The share price has seen a 52-week high of Rs 193.55 and a low of Rs 109 on BSE.

Current EPS & P/E ratio stood at 5.80 and 33.74 respectively.

Dabur India Ltd declared that its board members will meet on June 18, 2010, inter alia, to mull over and approve the audited financial results for the financial year ended March 31, 2010 and declaration of final dividend, if any, for the financial year ended March 31, 2010.

Dabur India is the country's top FMCG Company with revenues of US$ 599 million.

Resting on a legacy of excellence and know-how for more than 120 years, Dabur is presently India's most trusted name and the world's major Ayurvedic and Natural Health Care Company.

Todat, the company's portfolio comprises five flagship brands with distinguishable brand identities -- Dabur as the leading brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Réal for fruit-based beverages and Anmol for reasonable personal care business.

Dabur remains dedicated to drive expansion forcefully and augment the investor value.